Publications by authors named "Hadar Marcus"

Claim this Profile
U
Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults.
Yoseph Caraco, Noa Madar-Balakirski, Eytan Ben-Ami, David Zeltser, Shlomo Maayan, Hadar Marcus

Vaccine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
Dani Cohen, Marina Izak, Evgeniy Stoyanov, Michal Mandelboim, Saritte Perlman, Hadar Marcus

Int J Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mind the Gap-A Perspective on Strategies for Protecting against Bacterial Infections during the Period from Infection to Eradication.
Yoav Gal, Hadar Marcus, Emanuelle Mamroud, Ronit Aloni-Grinstein

Microorganisms· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel85 Protects K18-hACE2 Mice against Lethal Virus Challenge.
Ram Nechooshtan, Sharon Ehrlich, Marika Vitikainen, Arik Makovitzki, Eyal Dor, Hadar Marcus

Vaccines (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.
Amir Rosner, Michal Steiner, Sharon Melamed, Boaz Politi, Einat Vitner, Hadar Marcus

Arch Toxicol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.
Noa Madar-Balakirski, Amir Rosner, Sharon Melamed, Boaz Politi, Michal Steiner, Hadar Marcus

Arch Toxicol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Quantitative Multi-Component Serological Assay for SARS-CoV-2 Vaccine Evaluation.
Morly Fisher, Alon Manor, Hagar Abramovitch, Ella Fatelevich, Yafa Afrimov, Hadar Marcus

Anal Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.
Yfat Yahalom-Ronen, Noam Erez, Morly Fisher, Hadas Tamir, Boaz Politi, Hadar Marcus

Vaccines (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.
Tal Noy-Porat, Avishay Edri, Ron Alcalay, Efi Makdasi, David Gur, Hadar Marcus

Antibodies (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates.
Hadar Marcus, Emily Thompson, Yan Zhou, Michael Bailey, Mitzi M Donaldson

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.
Yotam Levin, Noa Madar Balakirski, Yoseph Caraco, Eytan Ben-Ami, Jacob Atsmon, Hadar Marcus

Vaccine· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.
Sabue Mulangu, Vivian H Alfonso, Nicole A Hoff, Reena H Doshi, Prime Mulembakani, Hadar Marcus

J Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
Davide Corti, John Misasi, Sabue Mulangu, Daphne A Stanley, Masaru Kanekiyo, Hadar Marcus

Science· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.
Eran Diamant, Bat-El Lachmi, Adi Keren, Ada Barnea, Hadar Marcus

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
Adva Mechaly, Haim Levy, Eyal Epstein, Ronit Rosenfeld, Hadar Marcus

J Biol Chem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infection.
Ronit Rosenfeld, Hadar Marcus, Einat Ben-Arie, Bat-El Lachmi, Adva Mechaly

PLoS One· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits.
Shay Weiss, David Kobiler, Haim Levy, Hadar Marcus, Avi Pass

Infect Immun· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus.
Nadav Orr, Moshe Forman, Hadar Marcus, Shlomo Lustig, Nir Paran

J Infect Dis· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
Hadar Marcus, Rachel Danieli, Eyal Epstein, Baruch Velan, Avigdor Shafferman

Infect Immun· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human colon adenocarcinoma in the SCID/CB6 radiation chimera is susceptible to adoptive transfer of allogeneic human peripheral blood mononuclear cells.
Fabian D Arditti, Ron Greenberg, Benjamin Dekel, Hadar Marcus, Arnon Nagler

J Hematother Stem Cell Res· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells from newborn humans are fully capable of developing into cytotoxic T lymphocyte effector cells in adoptive hosts.
Hadar Marcus, Benjamin Dekel, Fabian D Arditti, Shlomit Reich-Zeliger, Harry Segal

Transplantation· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis